ABEMACICLIB SECRETS

Pharmacological inhibition in the ataxia telangiectasia and Rad3-associated protein serine/threonine kinase (ATR; also called FRAP-related protein (FRP1)) has emerged to be a promising approach for most cancers therapy that exploits artificial lethal interactions with proteins involved in DNA hurt restore, overcomes resistance to other therapies an